Tag: MindMed - Page 8 - Psychedelic Alpha

Read more about the article MindMed Announces $50 Million Bought Deal Public Offering

MindMed Announces $50 Million Bought Deal Public Offering

Post published:December 15, 2020
Post category:Press Release

Read more about the article MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

Post published:December 14, 2020
Post category:Press Release

Read more about the article MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)

MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)

Post published:December 11, 2020
Post category:Press Release

Read more about the article MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

Post published:December 9, 2020
Post category:Press Release

Read more about the article MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:November 30, 2020
Post category:Press Release

Read more about the article MindMed Announces $25 Million Bought Deal Public Offering, Units Priced at $1.90

MindMed Announces $25 Million Bought Deal Public Offering, Units Priced at $1.90

Post published:November 25, 2020
Post category:Press Release

Read more about the article MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines

MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines

Post published:November 24, 2020
Post category:Press Release

Read more about the article MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

Post published:November 16, 2020
Post category:Press Release

Read more about the article MindMed Announces Q3 2020 Financial Results

MindMed Announces Q3 2020 Financial Results

Post published:November 13, 2020
Post category:Press Release

Read more about the article MindMed Completes Phase 1 LSD Dosing Study

MindMed Completes Phase 1 LSD Dosing Study

Post published:November 2, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.